InspireMD (NSPR) vs Retractable Technologies (RVP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Retractable Technologies (RVP) has outperformed InspireMD (NSPR) over the past year, losing 28.0% versus a loss of 80.3%. Over five years, NSPR leads with a -88.7% price change compared with -92.8% for RVP. InspireMD is the larger company by market cap ($24.2 million vs $19.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NSPR | RVP |
|---|---|---|
| Share price | $0.521 | $0.6632 |
| Market cap | $24.22M | $19.85M |
| 1-day change | +8.54% | +0.18% |
| YTD return | -73.03% | -14.03% |
| 1-year return | -80.33% | -28.04% |
| 5-year return | -88.68% | -92.76% |
| EPS (TTM) | $-0.62 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.54 | $1.14 |
| 52-week low | $0.46 | $0.60 |
| Distance from 52-week high | -79.49% | -41.82% |
| Analyst consensus | none | — |
| Avg. price target upside | +539.16% | — |
| Average volume | 79.31K | 27.81K |
| Shares outstanding | 46.49M | 29.94M |
| Employees | 127 | 195 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RVP has outperformed NSPR by 52.3 percentage points over the past year.
About InspireMD
NSPR stock →InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions.
Health Care · Medical/Dental Instruments · 127 employees
About Retractable Technologies
RVP stock →Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Health Care · Medical/Dental Instruments · 195 employees
NSPR vs RVP FAQ
Which is bigger, InspireMD or Retractable Technologies?
InspireMD (NSPR) is larger, with a market capitalization of $24.22M compared with $19.85M for Retractable Technologies (RVP).
Which stock has performed better over the past year, NSPR or RVP?
RVP returned -28.04% over the past 12 months, compared with -80.33% for NSPR (price return, excluding dividends). Past performance does not predict future results.
Are InspireMD and Retractable Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.